New Key Statistics Module, Z-Score and F-Score
NAS:TSHA Key Ratios
| Market Cap $ M | 577.89 |
| Enterprise Value $ M | 514.61 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 10.66 |
| Price/Sales | 28.34 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 14.00 |
| EPS (TTM) $ | -1.16 |
| Beneish M-Score | -1.81 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -4.50 |
| EV-to-EBITDA | -4.55 |
| PEG | -- |
| Shares Outstanding M | 187.02 |
| Net Margin (%) | -833.60 |
| Operating Margin % | -559.09 |
| Pre-tax Margin (%) | -833.60 |
| Quick Ratio | 3.38 |
| Current Ratio | 3.38 |
| ROA % (ttm) | -83.73 |
| ROE % (ttm) | -2,137.00 |
| ROIC % (ttm) | -99.52 |
| Dividend Yield % | -- |
| Altman Z-Score | -3.07 |
TSHA Number of Guru Trades
TSHA Volume of Guru Trades
Gurus Latest Trades with NAS:TSHA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TSHA is held by these investors
Total 1
Taysha Gene Therapies Inc Insider Transactions
No Available Data
News about NAS:TSHA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers